Dale B. Schenk
Dale B. Schenk publishes mostly in Molecular Biology, Physiology and Oncology, on topics such as Alzheimer's disease research and treatments, Amyloidosis: Diagnosis, Treatment, Outcomes and Ion Transport and Channel Regulation.
- World rank
- #684,992 of 7,710,434 ranked researchers
- Rank in United States
- #232,038 of 1,627,098
- Works
- 46
- Citations
- 5.4k
- Citations per work
- 117.7
What does Dale B. Schenk research?
Dale B. Schenk's work is mostly in Biochemistry, Genetics and Molecular Biology (36%), Medicine (24%), Neuroscience (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences1940.7%
- Everything else1635.5%
- Health Sciences1123.8%
- Medicine1123.8%
- 1Molecular Biology31% of their works
- 2Physiology14% of their works
- 3Oncology7% of their works
- 4Cellular and Molecular Neuroscience5% of their works
- 5Cell Biology4% of their works
- 6Neurology3% of their works
Research topics
- Alzheimer's disease research and treatments
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Ion Transport and Channel Regulation
- Nuclear Receptors and Signaling
- Parkinson's Disease Mechanisms and Treatments
- Drug Transport and Resistance Mechanisms
- Cholinesterase and Neurodegenerative Diseases
- Pancreatic function and diabetes
Which keywords describe Dale B. Schenk's research?
The keywords of their largest research topics: Neurodegeneration, Oxidative Stress, Amyloid Hypothesis, Tau Pathology, Cardiac Amyloidosis, Transthyretin, Dopaminergic Neurons and Parkinson's Disease.
- ß-Cell Dysfunction
- Pancreatic Islets
- NR4A2
- Genetic Risk Factors
- Acetylcholinesterase
- Water Channels
- Parkinson's Disease
- Transthyretin
- Tau Pathology
- Oxidative Stress
- Neurodegeneration
- Amyloid Hypothesis
- Cardiac Amyloidosis
- Dopaminergic Neurons
- Aquaporins
- ATP-dependent Transporters
- Cholinesterase Inhibitors
- Multidrug Resistance
- Nurr1
- a-Synuclein
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Neurodegeneration233 topics
- Oxidative Stress233 topics
- Amyloid Hypothesis151 topic
- Tau Pathology151 topic
- Cardiac Amyloidosis111 topic
- Transthyretin111 topic
- Dopaminergic Neurons82 topics
- Parkinson's Disease82 topics
- Aquaporins51 topic
- Water Channels51 topic
- ATP-dependent Transporters41 topic
- Acetylcholinesterase41 topic
- Cholinesterase Inhibitors41 topic
- Genetic Risk Factors41 topic
- Multidrug Resistance41 topic
- NR4A241 topic
- Nurr141 topic
- Pancreatic Islets41 topic
- a-Synuclein41 topic
- ß-Cell Dysfunction41 topic
Where does Dale B. Schenk work?
Dale B. Schenk's main affiliation in the publication record is Athena Group (United States), United States.
How many publications and citations does Dale B. Schenk have?
OpenAlex counts 46 works and 5,414 citations for Dale B. Schenk, an h-index of 28, ranking #684,992 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Dale B. Schenk. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.